INTRODUCTION
============

Crohn's disease (CD) is an inflammatory bowel disease that can affect the entire gastrointestinal tract, although the small bowel is the most commonly affected site.[@b1-gnl-11-062] According to population-based epidemiologic studies, \>50% of CD patients in Western countries[@b2-gnl-11-062]--[@b4-gnl-11-062] and up to 77.0% to 87.7% of CD patients in Asian countries had small bowel involvement at diagnosis.[@b5-gnl-11-062],[@b6-gnl-11-062] Therefore, the evaluation of the small and large intestine is essential for the diagnosis of CD, although no pathognomonic features have been identified for endoscopic and radiologic studies. Such an evaluation is particularly vital in cases where ileoscopy is unsuccessful or where the distal ileum is not involved.

Small bowel radiography (e.g., small bowel follow-through \[SBFT\] and enteroclysis \[EC\]), colonoscopy with ileoscopy, and push enteroscopy (PE) are commonly available modalities for small bowel evaluation. Due to the limitations of each technique, it is difficult to adequately assess small bowel disease, particularly in cases with subtle mucosal changes or wherein the distal ileum is not involved. Considerable technological advancements, such as capsule endoscopy (CE), computed tomography enterography (CTE), and magnetic resonance enterography (MRE) have recently enabled a more accurate investigation of the small bowel.

Several previous meta-analyses have indicated that CE has superior diagnostic effectiveness, as compared to other modalities.[@b7-gnl-11-062],[@b8-gnl-11-062] Rapid technological advancements have been made in the era of CE and radiological evaluations, including CTE or MRE. In the present study, we aimed to evaluate the diagnostic yield of CE, compared with other diagnostic modalities, in patients with suspected and established CD, using previous and newly published studies.

MATERIALS AND METHODS
=====================

1. Search strategy
------------------

A literature search was performed using core databases such as MEDLINE, EMBASE, and Cochrane Library, for all articles published up to March 2014. Moreover, eight domestic research databases were searched, including KoreaMed and KMBASE. Furthermore, manual searches were also performed. After reviewing previous related studies and abstracts, key clinical questions regarding the safety and effectiveness of CE, as well as the patient, intervention, comparators and outcomes (PICO) factors, were defined. The search terms were related to the intervention, and modified according to the index terms of each database, such as Medical Subject Heading (MeSH) and EMTREE. Extensive searches of the databases were performed using keywords such as "capsule endoscopy", "VCE", "SBCE", and "WCE."

2. Study selection criteria
---------------------------

Study selection was performed based on predefined inclusion/exclusion criteria. Studies that met the following criteria were included: (1) the study population included patients with small bowel CD; (2) the intervention was CE; (3) study design included randomized controlled trials, nonrandomized studies, and diagnostic studies; (4) modalities compared included PE, CTE, MRE, and EC; (5) one of the predetermined outcomes was reported; and (6) the language was English or Korean.

Studies on animals or preclinical studies, as well as articles other than original articles (e.g., reviews, editorials, letters, conference abstracts, and comments) were excluded. Articles not published in either English or Korean, and studies with duplicate subjects (i.e., different studies using the same outcome indicators in the same patient) were also excluded.

3. Outcomes
-----------

Diagnostic yield and diagnostic accuracy were the main outcome indicators of the effectiveness of CE. Patient satisfaction, therapeutic impact on further treatment, and additional diagnostic information gain in comparison to other modalities were considered as secondary outcomes. Capsule retention, incomplete diagnostic information, and other complications related to the CE procedure were investigated as safety outcomes.

4. A quality appraisal tool: Quality Assessment of Diagnostic Accuracy Studies-II
---------------------------------------------------------------------------------

Determination of study design quality was performed using the Quality Assessment of Diagnostic Accuracy Studies-II (QUADAS-II) tool.[@b9-gnl-11-062] QUADAS-II is a quality appraisal tool used in diagnostic studies. The four domains comprise patient selection, index test, reference standard, and flow and timing. The risk of bias and applicability of concerns were determined for individual studies, and were graded as "low," "high," or "unclear." Some items were modified according to the PICO factors, such as in cases where the predefined threshold or cutoff was not applicable; in these cases, researchers did not evaluate these items.

There is no single reference standard for the diagnosis of suspected CD. After consulting a methodologist, the opinion of clinical experts or consensus among experts, based on all the available tests performed for suspected CD, was considered as a reference standard.

5. Data extraction and analysis
-------------------------------

Using a pre-agreed data extraction format, two investigators independently extracted the data for review. The diagnostic yield, weighted incremental yield (IYw), and 95% confidence interval (CIs) were calculated.[@b10-gnl-11-062] A random effect model was used to account for heterogeneity. However, in subgroup analysis, we used a fixed model for data that showed low heterogeneity. The extracted data were synthesized both quantitatively and qualitatively. A group of experts, comprising gastrointestinal clinicians and evidence-based medicine specialists, guided each stage. Statistical analysis was performed using Cochrane RevMan version 5.3 (The Nordic Cochrane Centre, The Cochrane Collaboration, 2014; RevMan, Copenhagen, Denmark).

RESULTS
=======

1. Study characteristic and quality assessment
----------------------------------------------

All the stages, from the literature search to the application of the selection criteria and data extraction, were independently performed by two researchers. A total of 7,498 studies were retrieved from the database. After exclusion of duplicates, 5,811 studies remained. Finally, 24 studies[@b11-gnl-11-062]--[@b34-gnl-11-062] were selected according to the selection and exclusion criteria ([Fig. 1](#f1-gnl-11-062){ref-type="fig"}). The study characteristics are presented in [Table 1](#t1-gnl-11-062){ref-type="table"}. The findings of the quality assessment of all the included studies, using the QUADAS-II tool, are shown in [Fig. 2](#f2-gnl-11-062){ref-type="fig"}. The "reference standard" domain showed a relatively low rate of "low risk of bias" as compared to the others.

2. Comparison of diagnostic yield
---------------------------------

The diagnostic yield was reported in 19 studies. The data were analyzed according to the target population, including those with suspected or established CD.

In patients with suspected CD, CE was compared to SBFT, EC, CTE, and MRE ([Fig. 3](#f3-gnl-11-062){ref-type="fig"}). A total four studies[@b11-gnl-11-062],[@b13-gnl-11-062],[@b16-gnl-11-062],[@b32-gnl-11-062] compared CE and SBFT, but one study[@b32-gnl-11-062] was excluded in the meta-analysis because of high heterogeneity in the patient selection. The diagnostic yield of CE was statistically higher than that of SBFT (CE, 66.0% vs SBFT, 21.3%; IYw, 0.44; 95% CI, 0.29 to 0.59; I^2^, 30%). CE was compared with EC in two studies.[@b14-gnl-11-062],[@b28-gnl-11-062] CE showed a superior diagnostic yield as compared to EC (CE, 75.7% vs EC, 29.4%; IYw, 0.50; 95% CI, 0.21 to 0.79; I^2^, 52%). However, CE did not show a superior diagnostic yield as compared to CTE in two studies[@b13-gnl-11-062],[@b29-gnl-11-062] (CE, 72.5% vs CTE, 22.5%; IYw, 0.36; 95% CI, 0.18 to 0.90; I^2^, 68%). Moreover, CE did not show a significant superior diagnostic yield as compared to MRE in two studies (CE, 85.7% vs MRE, 100%; IYw, −0.16; 95% CI, −0.63 to 0.32; I^2^, 44%).[@b20-gnl-11-062],[@b27-gnl-11-062]

In patients with established CD, CE only showed a statistically superior diagnostic yield as compared to EC group in four studies (CE, 68.5% vs EC, 36.7%; IYw, 0.39; 95% CI, 0.28 to 0.50; I^2^, 0%).[@b14-gnl-11-062],[@b15-gnl-11-062],[@b17-gnl-11-062],[@b28-gnl-11-062] The diagnostic yield of other modalities, such as SBFT, CTE, MRE, and IC, was not significantly different as compared to that of CE ([Fig. 4](#f4-gnl-11-062){ref-type="fig"}).

3. Diagnostic accuracy
----------------------

The reference standards varied in the included studies. Therefore, quantitative data was not synthesized for the calculation of diagnostic accuracy, although the sensitivity and specificity were calculated ([Table 2](#t2-gnl-11-062){ref-type="table"}).

In patients with suspected CD, two studies reported that the sensitivity and specificity of CE were 62% to 100% and 50% to 100%, whereas those for MRE were 77% and 80%, respectively.[@b14-gnl-11-062],[@b16-gnl-11-062] SBFT had the lowest sensitivity (27.6%) and 100% specificity.

In patients with established CD, the sensitivity and specificity of CE was found to be 77% to 100% and 53% to 100% in seven studies, respectively.[@b14-gnl-11-062],[@b17-gnl-11-062],[@b19-gnl-11-062],[@b22-gnl-11-062],[@b25-gnl-11-062],[@b31-gnl-11-062],[@b33-gnl-11-062] The sensitivity and specificity of CTE were 76% to 82% and 85% to 89%, respectively, in two studies.[@b25-gnl-11-062],[@b31-gnl-11-062] Moreover, the sensitivity and specificity of MRE were 77% to 81% and 80% to 90%, respectively, in three studies.[@b14-gnl-11-062],[@b31-gnl-11-062],[@b33-gnl-11-062]

4. Detection of the terminal ileum lesion
-----------------------------------------

In the detection of lesions in the terminal ileum in cases of established CD, the use of CE was compared to the use of ileocolonoscopy (IC) or CTE ([Fig. 5](#f5-gnl-11-062){ref-type="fig"}) in five studies.[@b18-gnl-11-062],[@b19-gnl-11-062],[@b22-gnl-11-062],[@b24-gnl-11-062],[@b31-gnl-11-062] The diagnostic yield of CE was statistically higher than that of IC (CE, 60% vs IC, 48%; IYw, 0.11; 95% CI, 0.00 to 0.22; I^2^, 55%). However, the diagnostic yield of CE was not superior to that of CTE (CE, 40% vs CTE, 32%; IYw, 0.08; 95% CI, −0.02 to 0.19; I^2^, 84%).

5. Additional diagnostic gain
-----------------------------

A total four studies reported the additional lesions detected by CE. CE identified 40% (12/30) more lesions as compared to SBFT and small intestine contrast ultrasonography.[@b32-gnl-11-062] Moreover, CE identified a mucosal lesion in six patients who showed normal results on SBFT.[@b12-gnl-11-062] Furthermore, CE showed additional lesions that were not detected on MRE (9/52).[@b26-gnl-11-062] With regard to the detection of recurrent lesions in the terminal ileum, CE showed two more lesions as compared to IC.[@b19-gnl-11-062]

The satisfaction of patients with CE, as compared to other modalities, has been reported in two studies. Patients preferred CE to MRE or balloon-assisted enteroscopy (2.73 vs 1.43 and 1.85, p\<0.001) due to the lower burden of the examination in terms of discomfort during insertion, pain, and difficulty in swallowing.[@b34-gnl-11-062] Moreover, CE was preferred to IC. Patients experienced greater discomfort during examination preparation and daily activities with IC (80%) than with CE (20%).[@b24-gnl-11-062]

6. Safety-related outcomes
--------------------------

A total of eight studies reported adverse events related to CE ([Table 3](#t3-gnl-11-062){ref-type="table"}).[@b12-gnl-11-062],[@b18-gnl-11-062],[@b21-gnl-11-062],[@b23-gnl-11-062],[@b25-gnl-11-062],[@b26-gnl-11-062],[@b32-gnl-11-062],[@b33-gnl-11-062] The most common adverse event included capsule retention (5.5%, 14 of 255 patients). Capsule malfunction was reported in one study (one of 28 patients), and abdominal pain was reported in one study. Incomplete examination results were reported in five studies ([Table 4](#t4-gnl-11-062){ref-type="table"}).[@b14-gnl-11-062],[@b15-gnl-11-062],[@b17-gnl-11-062],[@b21-gnl-11-062],[@b28-gnl-11-062] However, incomplete examination results in CE were only noted in 7.5% patients (12 of 160 patients), as compared to those noted in other modalities (MRE, 12%; IC, 24%; and EC, 10.5%).

DISCUSSION
==========

In the present study, we provided updated information from published relevant systematic reviews, and focused on the additional diagnostic gain with the use of CE in the clinical field. Similar previous meta-analyses focused on a comparison of the diagnostic yield; however, these studies included data from abstracts that were excluded in the present study as they yield inconsistent result.[@b7-gnl-11-062],[@b8-gnl-11-062],[@b35-gnl-11-062] For a more precise comparison of diagnostic yield, we only included published studies, and divided the patients into cases with suspected and established CD. Moreover, a subgroup analysis was performed to identify the effectiveness of the diagnosis of terminal ileum lesions. Furthermore, we attempted to identify the additional diagnostic information or benefits in CD patients, including patient preference or satisfaction as well as adverse events.

Previous studies assumed that there would be different benefits for each patient group, and they indicated different results based on each patient group.[@b7-gnl-11-062],[@b8-gnl-11-062],[@b35-gnl-11-062] In the present study, the diagnostic yield of CE was found to be superior to that of other modalities in several subgroup comparisons, although not all the comparisons showed consistency in effectiveness. In cases of suspected CD, CE showed a higher diagnostic yield as compared to SBFT and EC. As no reference standard has been established, it is difficult to identify lesions in asymptomatic patients; however, an advantage of CE is that it enables the visualization of the entire small bowel, and hence, small bowel lesions can be easily and directly detected.[@b36-gnl-11-062] Our results may reflect this phenomenon. In contrast, in cases of established CD, CE showed a higher diagnostic yield as compared to EC; this has been also observed in previous studies.[@b7-gnl-11-062],[@b8-gnl-11-062] A previous meta-analysis on CE indicated that it had a higher diagnostic yield as compared to CTE in the cases with established disease and not in the cases with suspected disease.[@b8-gnl-11-062] However, that study included abstracts and studies that were still in press. CD is frequently accompanied by extraluminal inflammation. In such cases, CTE and MRE may serve as more useful diagnostic modalities.[@b37-gnl-11-062] Thus, our results reflect the strengths and limitations of CE.

In most patients with CD, the lesions are located in the terminal ileum, which can be accessed by IC.[@b36-gnl-11-062] Previous meta-analyses did not report any comparisons of modalities based on the lesions of this area; however, we performed such a comparison in the subgroup analysis. With regard to the detection of the recurrence of terminal ileum lesions, CE has a more superior diagnostic yield than IC, but a comparable diagnostic yield with CTE. The small bowel beyond the duodenum and proximal to the terminal ileum is inaccessible in conventional endoscopy;[@b36-gnl-11-062] therefore, CE would be a useful modality to examine terminal ileum lesions.

Although the included studies reported on the diagnostic accuracy, different reference standards have been used, as shown [Table 1](#t1-gnl-11-062){ref-type="table"}. SBFT and EC have been regarded as reference standard for radiographic assessment, but CTE and MRE are more accurate for the diagnosis of CD.[@b36-gnl-11-062] In the present study, we could not determine whether CE had a superior diagnostic performance as compared to MRE or CTE. CD can be accompanied by extraluminal inflammation, and MRE and CTE are relatively novel and enhanced radiographic diagnostic methods that are more accurate for diagnosis as compared to SBFT or EC in such cases.[@b36-gnl-11-062] Moreover, MRE is particularly useful for detecting transmural inflammation, stenosis, and extraintestinal lesions including abscesses and fistula.[@b26-gnl-11-062],[@b37-gnl-11-062] However, diagnostic effectiveness should not be judged based on diagnostic performance alone. The characteristics of CD such as systemic inflammation as well as recurrence are difficult to detect.[@b37-gnl-11-062] CE shows the entire small bowel through the canal, and has a higher successful completion rate than other endoscopic modalities. One systematic review reported a pooled completion rate of CE of 84.4%, wherein single-arm studies were included.[@b38-gnl-11-062]

Moreover, patient preference and additional diagnostic gain should be considered in the clinical decision. Patient satisfaction was higher in the CE group, in terms of comfort during the procedure, as compared to other diagnostic methods. The most frequent adverse event related to CE was capsule retention. In the present study, the capsule retention rate was 5.4%. One systematic review reported a retention rate of 2.6%, although this review included single-arm studies, and hence included a large number of studies.[@b38-gnl-11-062] A previous study of a large cohort reported a retention rate of 8.3% in CD.[@b39-gnl-11-062] Capsule retention primarily occurs in cases of luminal stricture and stenosis.[@b26-gnl-11-062] Therefore, in cases without stricture or stenosis of the bowel lumen, the use of CE is appropriate, as the retention rate would be acceptable.

This study has certain limitations. As the heterogeneity of the data was high, we performed subgroup analysis according to the patients and modalities. Therefore, the number of studies included in each subgroup analysis was too small to determine whether the effectiveness was significant. Moreover, there were differences in the reference standards and procedure settings, such as the interval of test timing and patient severity; this may also affect heterogeneity. In those studies used in this meta-analysis, as the patients of CD with known strictures which can be present in up to 25% of CD were excluded, the results have shown the yield of CE in a subgroup of patients with nonstricturing CD. If this population was included in the meta-analysis, the diagnostic yield of CTE and MRE would be higher. Other than that, the lack of a reference and/or gold standard may results in a confirmation bias, which may favor CE. CE found small bowel abnormality in about 20% of asymptomatic control patients,[@b40-gnl-11-062] suggesting that many findings on CE maybe nonspecific and unrelated to the CD.

Our meta-analysis demonstrates that CE is superior to SBFT and EC in the evaluation of suspected CD. CE is also a more effective diagnostic modality in patients with established CD, as compared to EC. Moreover, other modalities such as CTE or MRE showed a similar diagnostic performance compared to CE. However, CE may be an effective diagnostic method to diagnose patients who do not show any abnormality in radiographic screening without the risk of stricture or stenosis. Moreover, CE can be more helpful in identifying terminal ileum lesions as compared to IC. In addition, patients appear to prefer CE over other modalities.

Larger prospective studies are needed to establish the role of CE for diagnosing suspected small bowel CD and evaluating established CD. As it is unknown whether these results will translate into improved patient outcomes or decrease health care expenditures with CE versus other modalities, randomized controlled trials will be necessary to answer these questions.

This study was funded by the National Evidence-based Healthcare Collaborating Agency (NECA), project number: NECA-C-14-008.

See editorial on page 5.
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###### 

Characteristics of the Included Studies

  Author (year)                                   Country         Patients (N)                         Intervention (N)   Comparators (N)   Reference standard (N)                                               Reported outcomes
  ----------------------------------------------- --------------- ------------------------------------ ------------------ ----------------- -------------------------------------------------------------------- -----------------------------------
  Costamagna *et al*. (2002)[@b11-gnl-11-062]     Italy           Suspected small-bowel disease (20)   CE (20)            SBFT (22)         Colonoscopy (20)                                                     Diagnostic yield
  Buchman *et al*. (2004)[@b12-gnl-11-062]        United States   Suspected CD recurrence (30)         CE (30)            SBFT (30)         Clinician opinion (30)                                               Diagnostic yield
                                                                                                                                                                                                                 Correlation
                                                                                                                                                                                                                 Concordance
                                                                                                                                                                                                                 Additional diagnostic information
                                                                                                                                                                                                                 Patient satisfaction
  Eliakim *et al*. (2004)[@b13-gnl-11-062]        Israel          Suspected CD (35)                    CE (30)            SBFT (35)         IC and clinician opinion (35)                                        Diagnostic yield
                                                                                                                          CTE (35)                                                                               
                                                                                                                          IC (17)                                                                                Patient satisfaction
  Albert *et al*. (2005)[@b14-gnl-11-062]         Germany         Suspected and established CD (25)    CE (14)            MRI (25)          All data including IC (52)                                           Diagnostic accuracy
                                                                                                                          EC (24)                                                                                
  Chong *et al*. (2005)[@b15-gnl-11-062]          Australia       Crohn's history (43)                 CE (43)            PE (43)           IC and expert consensus (43)                                         Diagnostic yield
                                                                                                                          EC (43)                                                                                Therapeutic impact
  Dubcenco *et al*. (2005)[@b16-gnl-11-062]       Canada          Suspected CD (39)                    CE (39)            SBFT (39)         IC (39)                                                              Diagnostic yield
                                                                                                                                                                                                                 Diagnostic accuracy
  Marmo *et al*. (2005)[@b17-gnl-11-062]          Italy           Established CD (31)                  CE (31)            EC (31)           Comprehensive decision (31)                                          Diagnostic accuracy
                                                                                                                                                                                                                 Diagnostic yield
  Voderholzer *et al*. (2005)[@b18-gnl-11-062]    Germany         Established CD (56)                  CE (41)            CTE (41)          EGD or IC (56)                                                       Diagnostic yield
                                                                                                                                                                                                                 Therapeutic impact
  Bourreille *et al*. (2006)[@b19-gnl-11-062]     France          Operated CD (32)                     CE (31)            \-                IC (31)                                                              Diagnostic accuracy
  Gölder *et al*. (2006)[@b20-gnl-11-062]         Germany         Suspected and established CD (17)    CE (17)            MRE (17)          \-                                                                   Diagnostic yield
  Hara *et al*. (2006)[@b21-gnl-11-062]           United States   Suspected and established CD (17)    CE (17)            CTE (17)          IC (41)                                                              Diagnostic yield
                                                                                                                          SBFT (17)                                                                              
  Biancone *et al*. (2007)[@b22-gnl-11-062]       Italy           Established and operated CD (22)     CE (17)            SBFT (22)         IC (22)                                                              Diagnostic yield
                                                                                                                                                                                                                 Diagnostic accuracy
  Park *et al*. (2007)[@b23-gnl-11-062]           Korea           Established CD (52)                  CE (52)            SBFT (52)         Clinician opinion (52)                                               Diagnostic yield
                                                                                                                                                                                                                 Concordance
  Pons Beltrán *et al*. (2007)[@b24-gnl-11-062]   Spain           After operated CD (24)               CE (22)            IC (24)           Clinician opinion (24)                                               Diagnostic Yield
                                                                                                                                                                                                                 Patient Satisfaction
                                                                                                                                                                                                                 Therapeutic impact
  Solem *et al*. (2008)[@b25-gnl-11-062]          United States   Suspected and established CD (41)    CE (28)            CTE (41)          Expert consensus (41)                                                Diagnostic accuracy
                                                                                                                          IC (36)                                                                                
                                                                                                                          SBFT (38)                                                                              
  Tillack *et al*. (2008)[@b26-gnl-11-062]        Germany         Established CD (19)                  CE (19)            MRE (19)          Comprehensive determination (19)                                     Concordance
                                                                                                                                                                                                                 Additional diagnostic information
  Crook *et al*. (2009)[@b27-gnl-11-062]          Switzerland     Suspected CD (5)                     CE (5)             MRE (5)           Clinical, histological, biomedical data comprehensive decision (5)   Diagnostic accuracy
  Diagnostic yield                                                                                                                                                                                               
  Efthymiou *et al*. (2009)[@b28-gnl-11-062]      Greece          Suspected or established CD (55)     CE (55)            EC (55)           Expert consensus (55)                                                Diagnostic yield
  Rajesh *et al*. (2009)[@b29-gnl-11-062]         United States   Suspected CD (17)                    CE (5)             CTE (5)           Surgical and pathological gold standard data (17)                    Diagnostic yield
  Böcker *et al*. (2010)[@b30-gnl-11-062]         United States   Suspected and established CD (21)    CE (21)            MRI (21)          \-                                                                   Diagnostic yield
  Jensen *et al*. (2011)[@b31-gnl-11-062]         Denmark         Suspected or established CD (93)     CE (87)            MRE (89)          IC, IC+surgery, surgery (75)                                         Diagnostic accuracy
                                                                                                                          CTE (90)                                                                               Diagnostic yield
  Petruzziello *et al*. (2011)[@b32-gnl-11-062]   Italy           Suspected CD (30)                    CE (30)            SBFT (30)         Expert consensus (30)                                                Concordance
                                                                                                                          SICUS (30)                                                                             Diagnostic yield
                                                                                                                          IC (30)                                                                                Additional diagnostic information
  Wiarda *et al*. (2012)[@b33-gnl-11-062]         Netherland      Suspected or established CD (38)     CE (38)            MRE (38)          BAE+expert consensus (38)                                            Diagnostic accuracy
  Wiarda *et al*. (2013)[@b34-gnl-11-062]         Netherland      Suspected CD (38)                    CE (59)            MRE (76)          \-                                                                   Patient preference
                                                                  OGIB (38)                                               BAE (76)                                                                               Patient satisfaction

CE, capsule endoscopy; SBFT, small bowel follow-through; CD, Crohn's disease; IC, ileocolonoscopy; CTE, computed tomography enterography; MRI, magnetic resonance imaging; MRE, magnetic resonance enterography; PE, push enteroscopy; EC, enteroclysis; EGD, esophagogastroduodenoscopy; SICUS, small intestine contrast ultrasonography; BAE, Balloon-assisted enteroscopy; OGIB, obscure gastrointestinal bleeding.

###### 

Diagnostic Accuracy

  Author (year)                                  Reference standard (N)                Population       Subgroup                     Modalities (N)   Sensitivity, %   Specificity, %
  ---------------------------------------------- ------------------------------------- ---------------- ---------------------------- ---------------- ---------------- ----------------
  Suspected CD                                                                                                                                                         
   Albert *et al*. (2005)[@b14-gnl-11-062]       All clinical data including IC (52)   Suspected CD     \-                           CE (25)          92.0             100.0
                                                                                                                                     MRE (25)         77.0             80.0
   Dubcenco *et al*. (2005)[@b16-gnl-11-062]     IC (39)                               Suspected CD     \-                           CE (39)          89.6             100.0
                                                                                                                                     SBFT (39)        27.6             100.0
  Established CD                                                                                                                                                       
   Albert *et al*. (2005)[@b14-gnl-11-062]       All data including IC (52)            Established CD   \-                           CE (27)          92.0             100.0
                                                                                                                                     MRE (27)         77.0             80.0
   Marmo *et al*. (2005)[@b17-gnl-11-062]        Comprehensive decision (31)           Established CD   Established terminal ileum   CE (16)          87.0             \-
                                                                                                                                     EC (16)          37.0             \-
   Bourreille *et al*. (2006)[@b19-gnl-11-062]   Ileoscopy (32)                        Established CD   Lower                        CE (31)          62.0             90.0
                                                                                                        Upper                                         76.0             100.0
                                                                                                        Lower                        IC (31)          86.0             50.0
                                                                                                        Upper                                         86.0             79.0
   Biancone *et al*. (2007)[@b22-gnl-11-062]     IC (22)                               Established CD   Recurrence                   CE (22)          100.0            100.0
                                                                                                        Terminal ileum recur         CE (17)          93.0             67.0
   Solem *et al*. (2008)[@b25-gnl-11-062]        Expert consensus (41)                 Established CD                                CE (27)          83.0             53.0
                                                                                                                                     CTE (41)         82.0             89.0
   Jensen *et al*. (2011)[@b31-gnl-11-062]       IC, IC+surgery, surgery (75)          Established CD   \-                           CE (87)          100.0            91.0
                                                                                                                                     MRE (89)         81.0             86.0
                                                                                                                                     CTE (90)         76.0             85.0
   Wiarda *et al*. (2012)[@b33-gnl-11-062]       BAE+expert consensus (38)             Established CD   \-                           CE (38)          57.1             88.9
                                                                                                                                     MRE (38)         76.7             89.5

CD, Crohn's disease; IC, ileocolonoscopy; CE, capsule endoscopy; MRE, magnetic resonance enterography; SBFT, small bowel follow-through; EC, enteroclysis; CTE, computed tomography enterography; BAE, balloon-assisted enteroscopy.

###### 

Capsule-Related Adverse Events

  Author (year)                                   Capsule retention, % (n/N)   Capsule malfunction, % (n/N)   Cause (n)
  ----------------------------------------------- ---------------------------- ------------------------------ -------------------------------------------------------
  Buchman *et al*. (2004)[@b12-gnl-11-062]        6.7 (2/30)                   \-                             Small bowel stenosis (2)
  Voderholzer *et al*. (2005)[@b18-gnl-11-062]    4.9 (2/41)                   \-                             Terminal ileum inflammation (1), jejunal stenosis (1)
  Hara *et al*. (2006)[@b21-gnl-11-062]           5.9 (1/17)                   \-                             Small bowel stenosis (1)
  Park *et al*. (2007)[@b23-gnl-11-062]           9.6 (5/52)                   \-                             Small bowel stenosis (5)
  Solem *et al*. (2008)[@b25-gnl-11-062]          \-                           3.6 (1/28)                     Technical failure (1)
  Tillack *et al*. (2008)[@b26-gnl-11-062]        5.3 (1/19)                   \-                             Site of stenosis
  Petruzziello *et al*. (2011)[@b32-gnl-11-062]   3.3 (1/30)                   \-                             Ulcerated stenosis (1)
  Wiarda *et al*. (2012)[@b33-gnl-11-062]         2.6 (1/38)                   \-                             Small bowel stenosis (1)

###### 

Incomplete Examination Rate and Causes

  Author (year)                                Index test    Comparators                                                                                    
  -------------------------------------------- ------------- ---------------------------------------------------- ------------- ------------- ------------- ---------------------------------------
  Albert *et al*. (2005)[@b14-gnl-11-062]      7.1 (1/14)    Retention (1)                                        12.0 (3/25)   \-            8.3 (2/24)    \-
  Chong *et al*. (2005)[@b15-gnl-11-062]       2.3 (1/43)    Dysphagia (1)                                        \-            \-            13.9 (6/43)   Tube insertion failure and denial (6)
  Marmo *et al*. (2005)[@b17-gnl-11-062]       25.8 (8/31)   Cecum reach failure (2), low quality of result (6)   \-            \-            0 (0/31)      \-
  Hara *et al*. (2006)[@b21-gnl-11-062]        11.7 (2/17)   \-                                                   \-            23.5 (4/17)   \-            \-
  Efthymiou *et al*. (2009)[@b28-gnl-11-062]   0 (0/55)      \-                                                   \-            \-            1.5 (8/55)    Tube insertion failure (8)

CE, capsule endoscopy; MRE, magnetic resonance enterography; IC, ileocolonoscopy; EC, enteroclysis.
